fbpx

Analys

GRANGEX: Final regulatory hurdle cleared to materialise the world’s first CO2-free iron ore mine

Analys, Research

GRÄNGESBERG EXPLORATION The Land and Environmental Court has now granted GRANGEX the permit for mining operations at Dannemora, meaning...

Read More

AGTIRA: Key pieces in place for scalable growth

Analys, Research

With the framework agreement with Swedish real estate company NP3 Fastigheter in place, Agtira has added another key piece which should...

Read More

QLUCORE: Delayed CE approval suggests upcoming need for additional financing

Analys, Research

With BSI as Notified Body, Qlucore now expects to obtain CE certification for its Qlucore Diagnostics ALL application in February 2025....

Read More

KEBNI: Broad support for long-term revenue target but cash an increasing concern

Analys, Research

KebNi reported an 80% revenue growth in Q1’23, to SEK 10.9m, largely due to sales of satellite antennas to IAI. Despite a variety of...

Read More

CRUNCHFISH: Strong outlook to make 2023 a breakthrough year

Analys, Research

After an eventful 2022, Crunchfish looks to make 2023 the year where things take off. With one of the two Indian banks in the ongoing pilot...

Read More

NANEXA: Solid progress in development into 2023, with funding needs on the horizon

Analys, Research

After positive pre-clinical results in rats with NEX-22 (for treatment of type 2 diabetes) in Q1, we now see results from phase I for...

Read More

AGTIRA: Another Greenfood deal to drive growth

Analys, Research

In line with its ambitious growth plan, Agtira is now expanding its engagement with grocery producer and distributor Greenfood in a SEK...

Read More

GRANGEX: Anglo American-deal provides significant validation and financing for ambitious growth plan

Analys, Research

GRÄNGESBERG EXPLORATION After the DFS for Dannemora in Dec 2022 showing an IRR of 27% after tax, GRANGEX has now signed a two-fold deal...

Read More

SIMRIS GROUP: Lonza partnership brings ADC platform deals closer

Analys, Research

The strategic partnership with Lonza puts Simris in a stronger position going forward as it both validates Simris IP in the high value...

Read More

QLUCORE: Important milestone passed on the road to a more individualized cancer care

Analys, Research

The progress in Q3’22/23 (Nov–Jan) continues to support the long term case we’re seeing in Qlucore, where the company aims to provide...

Read More

For new research on growth stocks, sign up to our newsletter